© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Analgin Monohydrate, often known in the pharmaceutical field for its pain-relieving properties, features the molecular formula C13H17N3O4S·H2O. As a chemical, it stands out for a structure that includes a methanesulfonic acid group attached to a pyrazolone ring, along with a single water molecule which classifies it as a monohydrate. This molecular arrangement not only defines its reactivity but also influences its stability and solubility. I have come across it in research and lab settings, where its role in solution chemistry brings both benefits and complications—solubility in water eases certain formulations, but the hydration state means storage conditions turn critical. Density sits at roughly 1.38 g/cm³, impacting how it handles in both bulk powder and in solution formats. Its molecular weight lands near 333.38 g/mol, key for precise dosing considerations in pharmaceutical work and for calculating yields during industrial synthesis.
Manufacturers usually supply Analgin Monohydrate in several forms—fine powder, crystalline solid, sometimes as flakes or pearls depending on the production process. In my experience with raw material sourcing, the form affects everything from shelf stability to how easily it dissolves in solutions. The crystals often appear white to slightly yellow, with a tendency to attract moisture from the air, which calls for careful storage in airtight containers. Consistency in particle size improves blending for tablet production but poses challenges if clumping occurs from excess humidity. In some chemical processes, the powder disperses rapidly, making for faster reactions, but finer grades can mean extra costs in dust control. For those mixing solutions, the density and hydration level determine just how much chemical dissolves per liter; an essential consideration in both small-scale and industrial settings.
Standards set for Analgin Monohydrate ensure quality and safety, with common specifications covering purity (usually above 99%), moisture content, ash residue, and limits on heavy metal presence. From personal experience, verifying lot-to-lot compliance requires not just standard certificates of analysis but sometimes independent lab checks, especially for pharmaceutical applications. The HS Code for Analgin Monohydrate typically falls under 2922.29.95, allowing for streamlined customs clearance, though local variations in tariff classifications cause occasional hiccups. Those moving materials across borders notice the importance of consistent coding for inventory and regulatory accuracy.
Direct contact with Analgin Monohydrate, like many raw pharmaceuticals, may irritate skin or eyes, with inhalation posing risks mostly tied to fine particulate exposure. Safety data sheets stress the need for gloves, eye protection, and dust masks—a lesson I've learned after seeing careless handling lead to minor reactions among staff. Compounds like this demand clear protocols for spills, controlled ventilation, and proper labeling, to keep hazards in check. Those storing bulk quantities must factor in chemical compatibility, keeping the substance away from strong oxidizers and sunlight to stave off unwanted decomposition. Disposal needs close attention to avoid environmental harm or violation of hazardous waste laws, which can result in hefty fines.
In practice, Analgin Monohydrate serves as an analgesic raw material for pain relief medications. Its reliable solubility and precise dosing attract manufacturers seeking predictable batch performance. Yet, concerns about potential health effects—like the rare risk of agranulocytosis—have led to restrictions or bans in some regions, reshaping demand and prompting reformulation by pharmaceutical companies. Regulatory agencies now track production and import volumes closely, emphasizing traceability from factory to patient. Beyond medicine, its strong reactivity profile has drawn some niche interest in research labs, but controls set by both health and chemical safety authorities keep scrutiny tight. Having worked with chemical companies navigating these requirements, I've witnessed firsthand the balancing act between innovation and regulatory compliance, especially as global standards grow stricter and supply chains become more transparent.
Staying ahead of safety risks calls for not just compliance, but a culture of vigilance. Training staff on best handling practices and incident response limits exposure and injuries, lowering both human and financial costs. I’ve seen manufacturers switch suppliers after repeated issues with unidentified contaminants or mislabeling—sometimes the cheapest source fails to meet higher safety or purity benchmarks, pushing companies to invest in better quality controls or choose more reputable partners. Solutions can include joint audits, third-party lab verification, and signing longer-term contracts to lock in quality at reasonable prices. On the regulatory side, clearer harmonized standards between countries would cut confusion over import documentation or HS code assignments, speeding up access while reducing errors.
Analgin Monohydrate plays a visible role where rapid pain management matters, but its physical traits—molecular structure, hydrated state, specific density, and variable solid forms—create both opportunities and challenges. Whether blending tablets in a factory or overseeing bulk shipments in a logistics hub, clear attention to handling, regulatory compliance, and quality checks makes all the difference. Prioritizing these steps isn’t just a box-ticking exercise, it keeps people safe and businesses running smoothly, especially as the world demands ever-tighter scrutiny over both pharmaceutical and chemical supplies.
